Skip to main content
Equibles

CITIGROUP INC

Position in ARQT — Arcutis Biotherapeutics, Inc.

CIK 831001 NEW YORK, NY
Back to ARQT Full portfolio

Position in ARQT

as of Jun 30, 2026 · filed Aug 3, 2026
Position Value
$3,969,549
+$2,830,730 QoQ
Shares Held
151,394
+213.2% QoQ
Ownership
0.120%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#84
of 271 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in ARQT Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

CITIGROUP INC holds $2,085,225,397 across 384 Biotechnology names. ARQT ranks #80 (0.2% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 706,968 $351,172,214
2 REGN
Regeneron Pharmaceuticals, Inc.
 346,637 $216,142,034
3 MRNA
Moderna, Inc.
 2,165,414 $151,643,941
4 ROIV
Roivant Sciences Ltd.
 2,225,190 $78,749,472
5 ALNY
Alnylam Pharmaceuticals, Inc.
 227,786 $68,570,419
6 INCY
Incyte Corp
 586,431 $66,477,817
7 BBIO
BridgeBio Pharma, Inc.
 864,101 $64,358,241
8 RVMD
Revolution Medicines, Inc.
 247,052 $46,267,897

All Filings in ARQT

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $3,969,549 151,394
2026-03-31 $1,138,819 48,337
2025-12-31 $1,601,439 55,146
2025-09-30 $865,421 45,911
2025-06-30 $5,039,095 359,422
2025-03-31 $4,716,272 301,552
2024-12-31 $4,558,800 327,265
2024-09-30 $833,484 89,622
2024-06-30 $507,770 54,599
2024-03-31 $7,099,919 716,440
2023-12-31 $41,062 12,713
2023-09-30 $938,924 176,822
2023-06-30 $1,463,693 153,588
2023-03-31 $2,683,989 243,999
2022-12-31 $1,971,774 133,228
2022-09-30 $3,067,174 160,501
2022-06-30 $976,381 45,818
2022-03-31 $223,473 11,603
2021-12-31 $2,493,777 120,240
2021-09-30 $595,721 24,936
2021-06-30 $1,676,124 61,419
2021-03-31 $1,542,894 53,332
2020-12-31 $152,689 5,428
2020-09-30 $289,601 9,884
2020-06-30 $91,052 3,011
2020-03-31 $89,817 3,014